Los Angeles Capital Management LLC Cytosorbents Corp Transaction History

Los Angeles Capital Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 05, 2021	SELL	$7.55 - $9.42 $156,209 - $194,899	-20,690 Reduced 32.81%	42,378 $320,000
Q1 2021 May 05, 2021	BUY	$8.23 - $11.48 $8,888 - $12,398	1,080 Added 1.74%	63,068 $547,000
Q4 2020 Feb 04, 2021	SELL	$7.65 - $8.98 $23,026 - $27,029	-3,010 Reduced 4.63%	61,988 $494,000
Q3 2020 Nov 02, 2020	BUY	$7.37 - $11.54 $31,462 - $49,264	4,269 Added 7.03%	64,998 $518,000
Q2 2020 Aug 05, 2020	BUY	$6.28 - $10.59 $381,378 - $643,120	60,729 New	60,729 $601,000

16.9M

10.1K

500

Ticker CTSO
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 43,577,400
Market Cap $51.9M
Description
Cytosorbents Corporation engages in the research, development, and commercialization of medical devices with its blood purification technology platform incorporating a proprietary adsorbent and porous polymer technology. Its flagship product is CytoSorb, an extracorporeal cytokine filter for adjunctive therapy in the treatment of sepsis, adjunct...

Get notified when there are updates to the investment portfolio of Los Angeles Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Los Angeles Capital Management LLC with notifications on news.